Page 61 - SaxoCell Annual Report22/23

The on-site discussions resulted in a
concrete collaboration between the Israeli
company Aposense and scientists from the
SaxoCell project CARe-NK-AID. The industry
contacts made at BIO-EUROPE 2022 will be
regularly maintained in order to identify
further cooperation opportunities in the
future and to allow the network to grow
steadily and organically.

SaxoCell speaker Ezio Bonifacio opens the SaxoCell Symposium
An essential component of BIO-EUROPE is
also the lively partnering activity, which
enables an enormous number of different
players to network in order to explore
cooperation opportunities. In more than 60
partnering meetings with international
(Johnson & Johnson, Moderna, CureVac,
EliLilly) and national (BioNTech, PharmAI, The Hub team at the SaxoCell booth
Evonik, IDT Biologica) companies, our
SaxoCell transfer team was able to inquire
about the needs of the respective companies
in the field of current cell and gene therapy
activities and to explore possibilities for
cooperation. 56